DNA content can improve the detection and prognosis of carcinoma of the cervix

BioScience Trends

Volumn 4, Issue 3, 2010, Pages 103-109

  Chhavi, ^a   Saxena, Mona ^b   Negi, Mahendra P S ^c   Singh, Sharad ^a   Singh, Pankaj K ^a   Singh, Urmila ^a   Bhatt, M L B ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b Career Post Graduate Institute of Dental Sciences and Hospital   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

DNA content; Flow cytometry; G0 G1 (Aneuploid); G0 G1 (Diploid); Total S phase

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL CYCLE; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE; UTERINE CERVIX TUMOR;

ADULT; AGED; CELL CYCLE; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; ROC CURVE; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77957075437     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dabash R, Vajpayee J, Jacob M, Dzuba I, Lal N, Bradley J, Prasad LB. A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India. Reprod Health. 2005; 2:11. http:// www.reproductive-health-journal.com/content/2/1/11 (accessed January 13, 2009).
2. Lorenzato M, Clavel C, Masure M, Nou JM, Bouttens D, Evrard G, Bory JP, Maugard B, Quereux C, Birembaut P. DNA image cytometry and human papillomavirus (HPV) detection help to select smears at high risk of high-grade cervical lesions. J Pathol. 2001; 194:171-176.
3. Agency for Health Care Policy and Research (AHCPR). Evaluation of cervical cytology. Evidence report/ Technology assessment, No. 5. Rockville, MD, USA, 1999.
4. Pfisterer J, Kommoss F, Sauerbrei W, Baranski B, Kiechle M, Ikenberg H, Du Bois A, Pfleiderer A. DNA flow cytometry in stage IB and II cervical carcinoma. Int J Gynecol Cancer. 1996; 6:54-60.
5. Wilailak S, Rochanawutanon M, Srisupundit S, Aumkhyan A, Pattanapanyasat K. Flow cytometric analysis of DNA ploidy and S-phase fraction of Stage IIIB cervical carcinoma. Eur J Gynaecol Oncol. 2004; 25:428-430.
6. Driemel O, Kraft K, Hemmer J. DNA ploidy and proliferative activity in salivary gland tumours. Mund Kiefer Gesichtschir. 2007; 11:139-144.
7. Kulkarni AA, Loddo M, Leo E, Rashid M, Eward KL, Fanshawe TR, Butcher J, Frost A, Ledermann JA, Williams GH, Stoeber K. DNA replication licensing factors and aurora kinases are linked to aneuploidy and clinical outcome in epithelial ovarian carcinoma. Clin Cancer Res. 2007; 13:6153-6161.
8. Araujo SE, Bernardo WM, Habr-Gama A, Kiss DR, Cecconello I. DNA ploidy status and prognosis in colorectal cancer: a meta-analysis of published data. Dis Colon Rectum. 2007; 50:1800-1810.
9. Mangili G, Montoli S, De Marzi P, Sassi I, Aletti G, Aletti G, Taccagni G. The role of DNA ploidy in postoperative management of stage I endometrial cancer. Ann Oncol. 2008; 19:1278-1283.
10. Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice 109 guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet. 2000; 70:209-262.
11. Herrrington CS, Wells M. Premalignant and malignant squamous lesion of the cervix: invasive carcinoma. In: Obstetrical and Gynaecological Pathology (Fox H, Wells M, eds.). Churchill Livingstone, New York, USA, 2003; p. 326.
12. Vindelov LL, Christensen IJ, Nissen NI. A detergenttrypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983; 3:323-327.
13. Worthington Biochemical Corp. Cell isolation technique, basic primary cell isolation protocol. 2006. http://www. tissuedissociation.com (accessed February 21, 2006).
14. Rabinovitch PS. DNA content histogram and cell cycle analysis. In: Methods in cell biology. Vol. 41. Academic Press, New York, USA, 1994; pp. 263-296.
15. Alvarez RD, Potter ME, Soong SJ, Gay FL, Hatch KD, Partridge EE, Shingleton HM. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. Gynecol Oncol. 1991; 43:108-112.
16. Graflund M, Sorbe B, Hussein A, Bryne M, Karlsson M. The prognostic value of histopathologic grading parameters and microvessel density in patients with early squamous cell carcinoma of the uterine cervix. Int J Gynecol Cancer. 2002; 12:32-41.
17. McGuire WL. Breast cancer prognostic factors: evaluation guidelines. J Natl Cancer Inst. 1991; 83:154-155.
18. Todd R, Hinds PW, Munger K, Rustgi AK, Opitz OG, Suliman Y, Wong DT. Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med. 2002; 13:51-61.
19. Van Dam PA, Watson JV, Lowe DG, Chard T, Shepherd JH. Comparative evaluation of fresh, fixed, and cryopreserved solid tumor cells for reliable flow cytometry of DNA and tumor associated antigen. Cytometry. 1992; 13:722-729.
20. Atkin NB. The clinical usefulness of determining ploidy patterns in human tumors as measured by slide-based Feulgen microspectrophotometry. Anal Quant Cytol Histol. 1991; 13:75-79.
21. Kristensen GB, Kaern J, Abeler VM, Hagmar B, Tropé CG, Pettersen EO. No prognostic impact of flowcytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients. Gynecol Oncol. 1995; 57:79-85.
22. Jakobsen A. Ploidy level and short-time prognosis of early cervix cancer. Radiother Oncol. 1984; 1:271-275.
23. Raber MN, Barlogie B. DNA flow cytometry of human solid tumors. In: Flow Cytometry and Sorting (Melamed MR, Lindmo T, Mendelsohn ML, eds.). Wiley-Liss, New York, USA, 1990; pp. 745-754.
24. Lai CH, Hsueh S, Huang MY, Chang MF, Soong YK. The uses and limitations of DNA flow cytometry in stage IB or II cervical carcinoma. Cancer. 1993; 72:3655-3662.
25. Tagawa Y, Nakazaki T, Yasutake T, Matsuo S, Masao Tomita M. Comparison of pepsin and trypsin digestion on paraffin-embedded tissue preparation for DNA flow cytometry. Cytometry. 1993; 14:541-549.